Stay updated on Viagenpumatucel-L Combo Therapy in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Viagenpumatucel-L Combo Therapy in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Viagenpumatucel-L Combo Therapy in NSCLC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Results reporting information was added to the page, including the Results First Submitted date, QC criteria status, and the Results First Posted date. This makes the study results visible on the record.
    Difference
    0.3%
    Check dated 2025-11-03T01:29:29.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    33 days ago
    Change Detected
    Summary
    - Added a government funding lapse notice and current operating status guidance for NIH Clinical Center, and a version bump to v3.2.0. - Removed the previous version tag v3.1.0.
    Difference
    3%
    Check dated 2025-10-05T10:16:37.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    Update: version bumped from v3.0.2 to v3.1.0, indicating a new release. No other content changes are indicated.
    Difference
    0.1%
    Check dated 2025-09-28T03:18:44.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Page now shows Revision: v3.0.2, replacing the old v3.0.1; the 'Back to Top' element was removed.
    Difference
    0.2%
    Check dated 2025-09-13T17:39:05.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-06T15:18:16.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the addition of a new facility name and location in St. Louis, Missouri, as well as the introduction of new medical topics related to cancer and immunotherapy. Notably, several previous topics and terms related to lung cancer and certain immunological agents have been removed.
    Difference
    5%
    Check dated 2025-08-30T11:56:18.000Z thumbnail image

Stay in the know with updates to Viagenpumatucel-L Combo Therapy in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Viagenpumatucel-L Combo Therapy in NSCLC Clinical Trial page.